Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era

Author： McNamara Mairéad   Lwin Zarnie   Jiang Haiyan   Chung Caroline   Millar Barbara-Ann   Sahgal Arjun   Laperriere Normand   Mason Warren  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.117, Iss.1, 2014-03, pp. : 153-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression

By McNamara Mairéad   Lwin Zarnie   Jiang Haiyan   Templeton Arnoud   Zadeh Gelareh   Bernstein Mark   Chung Caroline   Millar Barbara-Ann   Laperriere Normand   Mason Warren  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 147-152

Springer Publishing Company

Access to resources Recommend Favorite

Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

O 6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

By Sonoda Yukihiko   Yokosawa Michiko   Saito Ryuta   Kanamori Masayuki   Yamashita Yoji   Kumabe Toshihiro   Watanabe Mika   Tominaga Teiji  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 352-358

Springer Publishing Company

Access to resources Recommend Favorite

Combination of the multipotent mesenchymal stromal cell transplantation with administration of temozolomide increases survival of rats with experimental glioblastoma

By            

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2828-2834

Spandidos Publications

Access to resources Recommend Favorite

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype

By            

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 17-26

Spandidos Publications

Access to resources Recommend Favorite